Navigating migraine care through the COVID-19 pandemic: an update

The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people particularly in their early and middle years, potentially reduces quality of life and productivity, and remains a common emergency presentation. This ar...

Full description

Saved in:
Bibliographic Details
Published inJournal of Neurology Vol. 268; no. 11; pp. 4388 - 4395
Main Authors Angus-Leppan, Heather, Guiloff, Angelica E., Benson, Karen, Guiloff, Roberto J.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Science and Business Media LLC 01.11.2021
Springer Berlin Heidelberg
Springer Nature B.V
Subjects
Acupuncture
Botulinum toxin
Communicable Disease Control
Coronary artery disease
Coronaviruses
COVID-19
COVID-19 - complications
Diabetes mellitus
Headache
Heart diseases
Humans
Immunosuppression
Long COVID
Medicine
Medicine & Public Health
Migraine
Migraine Disorders
Migraine Disorders - epidemiology
Migraine Disorders - therapy
Neurological Update
Neurology
Neuroradiology
Neurosciences
Pandemics
Post-Acute COVID-19 Syndrome
Quality of Life
Respiratory diseases
Risk factors
Telemedicine
COVID-19
Headache
CGRP antagonists
Telemedicine
Long COVID
Migraine
Online AccessGet full text

Cover

Abstract The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people particularly in their early and middle years, potentially reduces quality of life and productivity, and remains a common emergency presentation. This article examines the impact of COVID-19 on migraine, and changing aspects of migraine care during and after the pandemic. Many risk factors for severe COVID-19—older age, male gender, cardiac and respiratory diseases, diabetes, obesity, and immunosuppression—are less frequent in migraineurs. Telemedicine is effective for migraine follow-up, and needs ongoing evaluation. Most migraine treatments can start or continue in acute COVID-19, with care to avoid drug interactions. Close contact procedures (botulinum toxin, acupuncture and steroid injections) are avoided in lockdown or in the vulnerable. Secondary effects of COVID-19, including long COVID and its economic impact, are probably equal or greater in people with migraine. Migraine and other long-term conditions need adequate resourcing to prevent personal, social and economic suffering. Treating migraine, a sequel of COVID, potentially reduces the impact of long COVID.
AbstractList The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people particularly in their early and middle years, potentially reduces quality of life and productivity, and remains a common emergency presentation. This article examines the impact of COVID-19 on migraine, and changing aspects of migraine care during and after the pandemic. Many risk factors for severe COVID-19—older age, male gender, cardiac and respiratory diseases, diabetes, obesity, and immunosuppression—are less frequent in migraineurs. Telemedicine is effective for migraine follow-up, and needs ongoing evaluation. Most migraine treatments can start or continue in acute COVID-19, with care to avoid drug interactions. Close contact procedures (botulinum toxin, acupuncture and steroid injections) are avoided in lockdown or in the vulnerable. Secondary effects of COVID-19, including long COVID and its economic impact, are probably equal or greater in people with migraine. Migraine and other long-term conditions need adequate resourcing to prevent personal, social and economic suffering. Treating migraine, a sequel of COVID, potentially reduces the impact of long COVID.
The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people particularly in their early and middle years, potentially reduces quality of life and productivity, and remains a common emergency presentation. This article examines the impact of COVID-19 on migraine, and changing aspects of migraine care during and after the pandemic. Many risk factors for severe COVID-19-older age, male gender, cardiac and respiratory diseases, diabetes, obesity, and immunosuppression-are less frequent in migraineurs. Telemedicine is effective for migraine follow-up, and needs ongoing evaluation. Most migraine treatments can start or continue in acute COVID-19, with care to avoid drug interactions. Close contact procedures (botulinum toxin, acupuncture and steroid injections) are avoided in lockdown or in the vulnerable. Secondary effects of COVID-19, including long COVID and its economic impact, are probably equal or greater in people with migraine. Migraine and other long-term conditions need adequate resourcing to prevent personal, social and economic suffering. Treating migraine, a sequel of COVID, potentially reduces the impact of long COVID.The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people particularly in their early and middle years, potentially reduces quality of life and productivity, and remains a common emergency presentation. This article examines the impact of COVID-19 on migraine, and changing aspects of migraine care during and after the pandemic. Many risk factors for severe COVID-19-older age, male gender, cardiac and respiratory diseases, diabetes, obesity, and immunosuppression-are less frequent in migraineurs. Telemedicine is effective for migraine follow-up, and needs ongoing evaluation. Most migraine treatments can start or continue in acute COVID-19, with care to avoid drug interactions. Close contact procedures (botulinum toxin, acupuncture and steroid injections) are avoided in lockdown or in the vulnerable. Secondary effects of COVID-19, including long COVID and its economic impact, are probably equal or greater in people with migraine. Migraine and other long-term conditions need adequate resourcing to prevent personal, social and economic suffering. Treating migraine, a sequel of COVID, potentially reduces the impact of long COVID.
Author Karen Benson
R.J. Guiloff
Angelica E Guiloff
Heather Angus-Leppan
Author_xml – sequence: 1
  givenname: Heather
  orcidid: 0000-0001-7004-3848
  surname: Angus-Leppan
  fullname: Angus-Leppan, Heather
  email: heather.angus-leppan@nhs.net
  organization: Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Department of Clinical Neurosciences, Royal Free London NHS Foundation Trust
– sequence: 2
  givenname: Angelica E.
  surname: Guiloff
  fullname: Guiloff, Angelica E.
  organization: Northern Medical Centre, Barts and the London School of Medicine and Dentistry
– sequence: 3
  givenname: Karen
  surname: Benson
  fullname: Benson, Karen
  organization: The Crouch Hall Road Surgery
– sequence: 4
  givenname: Roberto J.
  surname: Guiloff
  fullname: Guiloff, Roberto J.
  organization: Faculty of Medicine, University of Chile, Imperial College Healthcare NHS Trust
BackLink https://cir.nii.ac.jp/crid/1871428067638913664$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/34002281$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu1TAUtFARvZT-AAsUCRZsAsfPOCyQqsurUkU3wNZyHCfXKHEudtKKv-dc0vLoorLkszgzozkzj8lRnKIn5CmFVxSgep0BBJUlMFpSUBTK6wdkQwVnJRWyPiIb4AJKyaU4Jqc5hwYAFD6hHpFjXAFjmm7I2Wd7FXo7h9gXY-iTDdEXziZfzLs0Lf0Opy-2l9_O35W0LvY2tn4M7k1hY7HsWzv7J-RhZ4fsT2_mCfn64f2X7afy4vLj-fbsonRS1XMpqBONraRwjRCsEU3t0E7TqUrV2natY8C4bGlbeVlZhOJ14CVrveYV6yw_IW9X3f3SjL51Ps7JDmafwmjTTzPZYP7fxLAz_XRlNGUaaooCL28E0vRj8Xk2Y8jOD4ONflqyYZJpTYWqOEKf34F-n5YU8TxEadBMy1oh6tm_jv5YuU0XAXoFuDTlnHxnXJgx6-lgMAyGgjl0adYuDXZpfndprpHK7lBv1e8l8ZWUERx7n_7avpf1YmXFENDg4ae6ogJTw3K4xuiUEvwXPQK5pg
CitedBy_id crossref_primary_10_33590_emj_10054250
crossref_primary_10_2147_JPR_S485548
crossref_primary_10_2196_30151
crossref_primary_10_1186_s10194_025_01961_0
crossref_primary_10_1136_bmj_2021_069494
crossref_primary_10_47795_ISHY1373
crossref_primary_10_3389_fneur_2021_744796
crossref_primary_10_3390_ijerph20043598
crossref_primary_10_1016_j_jocn_2022_01_006
crossref_primary_10_1055_s_0043_1763490
crossref_primary_10_1111_head_14769
Cites_doi 10.1186/s10194-017-0816-0
10.4103/ijmr.IJMR_585_20
10.1007/s10072-020-04702-0
10.1186/1756-0500-3-213
10.1080/03007995.2021.1900092
10.1111/jgs.13932
10.1136/practneurol-2015-001298
10.1177/0333102420965157
10.1136/bmj.k179
10.3389/fpsyg.2020.563722
10.1038/s41591-020-0916-2
10.1186/1471-2377-11-30
10.3389/fneur.2020.583870
10.1177/0333102420981739
10.1111/head.14056
10.7861/clinmed.2020-0232
10.1111/j.1526-4610.2012.02140.x
10.1128/JVI.00014-21
10.2196/23775
10.1177/0333102417738202
10.1111/head.14086
10.3389/fneur.2020.00565
10.1111/j.1532-5415.2011.03586.x
10.1161/CIRCRESAHA.120.317174
10.1186/s10194-020-01183-6
10.1111/head.13967
10.1046/j.1468-2982.2003.00568.x
10.1177/0333102420965132
10.1136/practneurol-2012-000502
10.7326/L20-1446
10.1002/ejhf.2060
10.1016/j.medidd.2020.100042
10.1016/j.nrl.2020.05.004
10.1186/s10194-020-01188-1
10.30773/pi.2019.04.11
10.1111/head.13998
10.1136/bmjophth-2020-000487
10.3389/fneur.2020.597881
10.1212/WNL.0000000000006697
10.21203/rs.3.rs-266574/v1
10.1016/j.ejphar.2021.173988
10.1038/s41582-020-00438-9
10.1007/978-1-4471-3787-0_23
10.1111/head.14030
10.1186/s10194-018-0946-z
10.1212/WNL.0000000000003919
10.1177/2472555220975672
10.1038/s41586-020-2521-4
10.1001/jamaneurol.2020.1127
10.1212/01.wnl.0000252808.97649.21
10.1111/head.13880
10.1136/bmj.m1985
10.1016/j.pec.2020.12.027
10.1038/nm1267
10.1136/bmj.i2610
10.1136/bmj.m1557
10.1152/ajpcell.00478.2020
10.1016/j.mehy.2020.109891
10.1016/S1474-4422(18)30322-3
10.1186/s13256-016-0835-5
10.1186/s10194-020-01106-5
ContentType Journal Article
Copyright Crown 2021
2021. Crown.
Crown 2021.
Copyright_xml – notice: Crown 2021
– notice: 2021. Crown.
– notice: Crown 2021.
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s00415-021-10610-w
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1459
EndPage 4395
ExternalDocumentID PMC8128091
34002281
10_1007_s00415_021_10610_w
Genre Journal Article
GroupedDBID ---
.86
.VR
06C
06D
0R~
0VY
199
1N0
203
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
36B
4.4
406
408
409
40D
40E
53G
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AAPKM
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHIR
ADIMF
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFJLC
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATHPR
AXYYD
AYFIA
AZFZN
B-.
BA0
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CCPQU
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EMB
EMOBN
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N9A
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNS
ROL
RPX
RRX
RSV
RYH
S16
S27
S37
S3B
SAP
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
ZMTXR
ZOVNA
~EX
~KM
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.GJ
2.D
28-
2P1
2VQ
3SX
3V.
5QI
AANXM
AARHV
AAYTO
ABQSL
ABULA
ACBXY
ACUDM
ADINQ
AEBTG
AEFIE
AEKMD
AFDYV
AFEXP
AFFNX
AGGDS
AJBLW
BBWZM
BDATZ
CAG
COF
EJD
EN4
FINBP
FSGXE
GQ6
GRRUI
H13
KOW
N2Q
NDZJH
O9-
OVD
RIG
RNI
RZK
S1Z
S26
S28
SCLPG
SDE
T16
TEORI
WK6
X7M
Z7U
Z81
Z82
Z83
Z87
Z8O
Z8U
Z8V
Z8W
Z91
Z92
ZGI
ZXP
AAYXX
ADHKG
AGQPQ
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c569t-41c4ba754cb442b4b9c606bf67698afdc20235d1d7e57a4ba4150e52de8372fa3
IEDL.DBID 7X7
ISSN 0340-5354
1432-1459
IngestDate Thu Aug 21 18:13:32 EDT 2025
Thu Jul 10 22:22:17 EDT 2025
Fri Jul 25 22:38:40 EDT 2025
Mon Jul 21 05:49:28 EDT 2025
Thu Apr 24 22:53:18 EDT 2025
Tue Jul 01 01:31:33 EDT 2025
Fri Feb 21 02:47:06 EST 2025
Fri Jun 27 00:57:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords COVID-19
Headache
CGRP antagonists
Telemedicine
Long COVID
Migraine
Language English
License 2021. Crown.
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-41c4ba754cb442b4b9c606bf67698afdc20235d1d7e57a4ba4150e52de8372fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9680-174x
0000-0001-7004-3848
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8128091
PMID 34002281
PQID 2580828596
PQPubID 47196
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8128091
proquest_miscellaneous_2528814673
proquest_journals_2580828596
pubmed_primary_34002281
crossref_citationtrail_10_1007_s00415_021_10610_w
crossref_primary_10_1007_s00415_021_10610_w
springer_journals_10_1007_s00415_021_10610_w
nii_cinii_1871428067638913664
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-11-01
PublicationDateYYYYMMDD 2021-11-01
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Journal of Neurology
PublicationTitleAbbrev J Neurol
PublicationTitleAlternate J Neurol
PublicationYear 2021
Publisher Springer Science and Business Media LLC
Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Science and Business Media LLC
– name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References KandasamyMPerspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19Med Drug Discov2020610004210.1016/j.medidd.2020.100042323520817189194
World Health Organisation. Headache disorders. https://www.who.int/news-room/fact-sheets/detail/headache-disorders. Accessed Jan 2021
BolayHOzgeAUluduzDAre migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities?Headache202060102508252110.1111/head.1399833124044
MenniCValdesAMFreidinMBReal-time tracking of self-reported symptoms to predict potential COVID-19Nat Med2020267103710401:CAS:528:DC%2BB3cXptVKhsrg%3D10.1038/s41591-020-0916-2323938047751267
World Health Organisation. Rapid assessment of service delivery for NCDs during the COVID-19 pandemic. https://www.who.int/publications/m/item/rapid-assessment-of-service-delivery-for-ncds-during-the-covid-19-pandemic. Accessed Mar 2021
World Health Organisation. WHO Living guideline: Drugs to prevent COVID-19 [January 2021].
DoTPRemmersASchytzHWRed and orange flags for secondary headaches in clinical practice: SNNOOP10 listNeurology201992313414410.1212/WNL.0000000000006697305875186340385
PittBSuttonNRWangZPotential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Eur J Pharmacol20218981739881:CAS:528:DC%2BB3MXlvV2qsr0%3D10.1016/j.ejphar.2021.1739883366745533667455
RozenTDDaily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian/Asiatic fluCephalalgia202040131406140910.1177/0333102420965132331460347645599
NegroADelaruelleZIvanovaTAHeadache and pregnancy: a systematic reviewJ Headache Pain20171811061:STN:280:DC%2BC1M7is12ntA%3D%3D10.1186/s10194-017-0816-0290520465648730
NaasaniICOMPARE analysis, a bioinformatic approach to accelerate drug repurposing against Covid-19 and other emerging epidemicsSLAS Discov20212633453511:CAS:528:DC%2BB3MXkvFCquro%3D10.1177/24725552209756723326771333267713
Santos-LasaosaSPorta-EtessamJOnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infectionNeurologia20203552912941:STN:280:DC%2BB38vnt1Srsg%3D%3D10.1016/j.nrl.2020.05.004324107657221361
Planchuelo-GomezATrigoJde Luis-GarciaRDeep phenotyping of headache in hospitalized COVID-19 patients via principal component analysisFront Neurol20201158387010.3389/fneur.2020.583870333911527773780
SafadiKKrugerJMChowersIOphthalmology practice during the COVID-19 pandemicBMJ Open Ophthalmol202051e00048710.1136/bmjophth-2020-00048732432169
TanHSFrereZKrishnamoorthyVAssociation of gabapentinoid utilization with postoperative pulmonary complications in gynecologic surgery: a retrospective cohort studyCurr Med Res Opin202110.1080/03007995.2021.190009234543161
CherianSSAgrawalMBasuAPerspectives for repurposing drugs for the coronavirus disease 2019Indian J Med Res20201512 & 31601711:CAS:528:DC%2BB3cXhvVCgtbrO10.4103/ijmr.IJMR_585_20323174087357399
NICE (2021) COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. https://www.nice.org.uk/advice/es23/chapter/Key-messages. Accessed Jan 2021
GelayeBSaccoSBrownWJBody composition status and the risk of migraine: a meta-analysisNeurology201788191795180410.1212/WNL.000000000000391954199815419981
Al-HashelJYIsmailIIImpact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey studyJ Headache Pain20202111151:CAS:528:DC%2BB3cXitVahu7zO10.1186/s10194-020-01183-6329723607513457
The Work Foundation. Migraine’s impact on employment in Europe. https://www.lancaster.ac.uk/work-foundation/?wp-content/uploads/2018/04/Society%e2%80%99s-headache-the-socioeconomic-impact-of-migraine.-Work-Foundation.pdf. Accessed Nov 2020
DochertyABHarrisonEMGreenCAFeatures of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyBMJ2020369m198510.1136/bmj.m1985324444607243036
KubaKImaiYRaoSA crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injuryNat Med20051188758791:CAS:528:DC%2BD2MXmvFemsL8%3D10.1038/nm1267160070977095783
Angus-LeppanHMigraine: mimics, borderlands and chameleonsPract Neurol201313530831810.1136/practneurol-2012-00050223906594
SteinerTJScherAIStewartWFThe prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicityCephalalgia20032375195271:STN:280:DC%2BD3svns1GhsQ%3D%3D10.1046/j.1468-2982.2003.00568.x12950377
KrishnamurthySLockeyRFKolliputiNSoluble ACE2 as a potential therapy for COVID-19Am J Physiol Cell Physiol1993303C279C2811:CAS:528:DC%2BB3MXhtVKjsLfP10.1152/ajpcell.00478.2020
KurthTWinterACEliassenAHMigraine and risk of cardiovascular disease in women: prospective cohort studyBMJ2016353i261010.1136/bmj.i2610272472814887613
ChatterjeeSCarnahanRMChenHAnticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control studyJ Am Geriatr Soc201664239440010.1111/jgs.1393226889844
TommasiMToroFArnoSPhysical and psychological impact of the phase one lockdown for COVID-19 on ItaliansFront Psychol20201156372210.3389/fpsyg.2020.563722333910797773646
CanelLZisimopoulouSBessonMTopiramate-induced severe heatstroke in an adult patient: a case reportJ Med Case Rep2016109510.1186/s13256-016-0835-5270750334831160
Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edn. In: Cephalalgia, vol 38, issue 1, pp 1–211. doi: https://doi.org/10.1177/0333102417738202
RavindranMKZhengYTimbolCMigraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studiesBMC Neurol2011113010.1186/1471-2377-11-30213757633058027
PinzonRTWijayaVOBuanaRBNeurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysisFront Neurol20201156510.3389/fneur.2020.00565325742507273516
MurthyVLKoupenovaMShahRVACEing COVID-19: a role for angiotensin axis inhibition in SARS-CoV-2 infection?Circ Res202012612168216841:CAS:528:DC%2BB3cXhtVylurvP10.1161/CIRCRESAHA.120.317174323022487274880
DouglasMKatikireddiSVTaulbutMMitigating the wider health effects of covid-19 pandemic responseBMJ2020369m155710.1136/bmj.m1557323410027184317
Oxford Centre for evidence based medicine (2011). www.cebm.net/ocebm-levels-of-evidence/. Accessed Nov 2020
SavareseGBensonLSundstromJAssociation between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysisEur J Heart Fail20212334764851:CAS:528:DC%2BB3MXpvFGjsL8%3D10.1002/ejhf.206033222412
CourtneyEBlackburnDReuberMNeurologists' perceptions of utilising tele-neurology to practice remotely during the COVID-19 pandemicPatient Educ Couns2021104345245910.1016/j.pec.2020.12.02733478853
MillerSSinclairAJDaviesBNeurostimulation in the treatment of primary headachesPract Neurol201616536237510.1136/practneurol-2015-001298271520275036247
JangYEChoEYChoiHYDiagnostic neuroimaging in headache patients: a systematic review and meta-analysisPsychiatry Investig201916640741710.30773/pi.2019.04.11312476996603699
CaronnaEBallveALlauradoAHeadache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolutionCephalalgia202040131410142110.1177/0333102420965157331460367645597
Global Burden of Disease Headache CollaboratorsGlobal, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Neurol2018171195497610.1016/S1474-4422(18)30322-3
Angus-LeppanHGuiloffRJHeadache: basic trial designs, sample sizes and pitfallsClinical trials in neurology2001LondonSpringer27929010.1007/978-1-4471-3787-0_23
PattersonVNeurological telemedicine in the COVID-19 eraNat Rev Neurol202117273741:CAS:528:DC%2BB3cXisFentrnP10.1038/s41582-020-00438-933257883
MackeyKKansagaraDVelaKUpdate Alert 7: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adultsAnn Intern Med20211742W25W2910.7326/L20-144633395346
ChenJSAlfajaroMMChowRDNon-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infectionJ Virol202110.1128/JVI.00014-21346138018428404
JamesHMPapoutsiCWhertonJSpread, scale-up, and sustainability of video consulting in health care: systematic review and synthesis guided by the NASSS frameworkJ Med Internet Res2021231e2377510.2196/23775334341417837451
GelfandAAPolandGMigraine treatment and COVID-19 vaccines: no cause for concernHeadache202110.1111/head.14086336169338013648
MartellettiPSchwedtTJLanteri-MinetMMy Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failedJ Headache Pain201819111510.1186/s10194-018-0946-z304821816755592
WakerleyBRMollanSPSinclairAJIdiopathic intracranial hypertension: update on diagnosis and managementClin Med (Lond)202020438438810.7861/clinmed.2020-0232
Angus-LeppanHSaatciDSutcliffeAAbdominal migraineBMJ2018360k17910.1136/bmj.k17929459383
UnalGTuranBBalciogluYHImmunopharmacological management of COVID-19: potential therapeutic role of valproic acidMed Hypotheses20201431098911:CAS:528:DC%2BB3cXhtVGls77I10.1016/j.mehy.2020.1098913249800732498007
GharaeiHDiwanSCOVID-19 pandemic: implications on interventional pain practice-a narrative reviewPain Physician2020234SS311S31832942791
Lopez-LeonSWegman-OstroskyTPerelmanCMore than 50 long-term effects of COVID-19: a systematic review and meta-analysisRes Sq202110.21203/rs.3.rs-266574/v1336886427941645
LiptonRBBigalMEDiamondMMigraine prevalence, disease burden, and the need for preventive therapyNeurology20076853433491:STN:280:DC%2BD2s%2FlslCgsg%3D%3D10.1212/01.wnl.0000252808.97649.2117261680
VerhagenIEvan CasterenDSde VriesLSEffect of lockdown during COVID-19 on
V Patterson (10610_CR31) 2021; 17
EJ Williamson (10610_CR9) 2020; 584
10610_CR62
M Douglas (10610_CR27) 2020; 369
A Maassen Van Den Brink (10610_CR41) 2020; 21
BR Wakerley (10610_CR36) 2020; 20
AB Docherty (10610_CR8) 2020; 369
H Bolay (10610_CR7) 2020; 60
T Kurth (10610_CR12) 2016; 353
K Safadi (10610_CR37) 2020; 5
S Chatterjee (10610_CR47) 2016; 64
S Santos-Lasaosa (10610_CR65) 2020; 35
TJ Schwedt (10610_CR64) 2021; 61
Global Burden of Disease Headache Collaborators (10610_CR2) 2018; 17
K Kuba (10610_CR59) 2005; 11
M Delussi (10610_CR30) 2020; 11
J Porta-Etessam (10610_CR66) 2020; 60
P Martelletti (10610_CR4) 2018; 19
HS Tan (10610_CR46) 2021
MK Ravindran (10610_CR70) 2011; 11
S Miller (10610_CR50) 2016; 16
JY Al-Hashel (10610_CR22) 2020; 21
RJ Guiloff (10610_CR24) 1988; 51
M Smith (10610_CR26) 2021; 61
S Lopez-Leon (10610_CR68) 2021
C Lupi (10610_CR53) 2020
TP Do (10610_CR35) 2019; 92
K Mackey (10610_CR48) 2021; 174
S Krishnamurthy (10610_CR58) 1993; 30
H Angus-Leppan (10610_CR14) 2013; 13
M Tommasi (10610_CR28) 2020; 11
IE Verhagen (10610_CR29) 2021
SJ Tepper (10610_CR43) 2012; 52
A Liu (10610_CR25) 2010; 3
G Unal (10610_CR55) 2020; 143
RB Lipton (10610_CR13) 2007; 68
L Mao (10610_CR16) 2020; 77
H Angus-Leppan (10610_CR19) 2001
HM James (10610_CR32) 2021; 23
E Caronna (10610_CR67) 2020; 40
TD Rozen (10610_CR69) 2020; 40
10610_CR40
I Naasani (10610_CR54) 2021; 26
TJ Steiner (10610_CR10) 2003; 23
SS Cherian (10610_CR57) 2020; 151
L Canel (10610_CR45) 2016; 10
VL Murthy (10610_CR60) 2020; 126
E Courtney (10610_CR33) 2021; 104
A Negro (10610_CR52) 2017; 18
RT Pinzon (10610_CR18) 2020; 11
JS Chen (10610_CR42) 2021
C Menni (10610_CR17) 2020; 26
JA Membrilla (10610_CR23) 2020; 60
H Gharaei (10610_CR51) 2020; 23
B Gelaye (10610_CR11) 2017; 88
10610_CR1
YE Jang (10610_CR38) 2019; 16
10610_CR39
G Savarese (10610_CR49) 2021; 23
10610_CR3
M Kandasamy (10610_CR61) 2020; 6
10610_CR5
10610_CR6
10610_CR34
H Angus-Leppan (10610_CR15) 2018; 360
S Dublin (10610_CR44) 2011; 59
B Pitt (10610_CR56) 2021; 898
A Planchuelo-Gomez (10610_CR20) 2020; 11
AA Gelfand (10610_CR63) 2021
O Uygun (10610_CR21) 2020; 21
References_xml – reference: CourtneyEBlackburnDReuberMNeurologists' perceptions of utilising tele-neurology to practice remotely during the COVID-19 pandemicPatient Educ Couns2021104345245910.1016/j.pec.2020.12.02733478853
– reference: MaoLJinHWangMNeurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, ChinaJAMA Neurol202077668369010.1001/jamaneurol.2020.112732275288
– reference: Al-HashelJYIsmailIIImpact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey studyJ Headache Pain20202111151:CAS:528:DC%2BB3cXitVahu7zO10.1186/s10194-020-01183-6329723607513457
– reference: PittBSuttonNRWangZPotential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Eur J Pharmacol20218981739881:CAS:528:DC%2BB3MXlvV2qsr0%3D10.1016/j.ejphar.2021.1739883366745533667455
– reference: Global Burden of Disease Headache CollaboratorsGlobal, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet Neurol2018171195497610.1016/S1474-4422(18)30322-3
– reference: World Health Organisation. Headache disorders. https://www.who.int/news-room/fact-sheets/detail/headache-disorders. Accessed Jan 2021
– reference: NegroADelaruelleZIvanovaTAHeadache and pregnancy: a systematic reviewJ Headache Pain20171811061:STN:280:DC%2BC1M7is12ntA%3D%3D10.1186/s10194-017-0816-0290520465648730
– reference: World Health Organisation. WHO Living guideline: Drugs to prevent COVID-19 [January 2021].
– reference: GharaeiHDiwanSCOVID-19 pandemic: implications on interventional pain practice-a narrative reviewPain Physician2020234SS311S31832942791
– reference: MembrillaJAde LorenzoISastreMHeadache as a cardinal symptom of coronavirus disease 2019: a cross-sectional studyHeadache202060102176219110.1111/head.1396732989732
– reference: World Health Organisation. Rapid assessment of service delivery for NCDs during the COVID-19 pandemic. https://www.who.int/publications/m/item/rapid-assessment-of-service-delivery-for-ncds-during-the-covid-19-pandemic. Accessed Mar 2021
– reference: SchwedtTJHentzJGSahai-SrivastavaSHeadache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the medication overuse treatment strategy trialHeadache202161235136210.1111/head.1405633432635
– reference: SavareseGBensonLSundstromJAssociation between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysisEur J Heart Fail20212334764851:CAS:528:DC%2BB3MXpvFGjsL8%3D10.1002/ejhf.206033222412
– reference: PinzonRTWijayaVOBuanaRBNeurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysisFront Neurol20201156510.3389/fneur.2020.00565325742507273516
– reference: LupiCNegroAGambassiEMedicines for headache before and during pregnancy: a retrospective cohort study (ATENA study)Neurol Sci202010.1007/s10072-020-04702-0329688698043957
– reference: MurthyVLKoupenovaMShahRVACEing COVID-19: a role for angiotensin axis inhibition in SARS-CoV-2 infection?Circ Res202012612168216841:CAS:528:DC%2BB3cXhtVylurvP10.1161/CIRCRESAHA.120.317174323022487274880
– reference: KubaKImaiYRaoSA crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injuryNat Med20051188758791:CAS:528:DC%2BD2MXmvFemsL8%3D10.1038/nm1267160070977095783
– reference: Maassen Van Den BrinkAde VriesTDanserAHJHeadache medication and the COVID-19 pandemicJ Headache Pain2020211381:CAS:528:DC%2BB3cXot1ams7o%3D10.1186/s10194-020-01106-5
– reference: MackeyKKansagaraDVelaKUpdate Alert 7: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adultsAnn Intern Med20211742W25W2910.7326/L20-144633395346
– reference: The Work Foundation. Migraine’s impact on employment in Europe. https://www.lancaster.ac.uk/work-foundation/?wp-content/uploads/2018/04/Society%e2%80%99s-headache-the-socioeconomic-impact-of-migraine.-Work-Foundation.pdf. Accessed Nov 2020
– reference: Angus-LeppanHMigraine: mimics, borderlands and chameleonsPract Neurol201313530831810.1136/practneurol-2012-00050223906594
– reference: DochertyABHarrisonEMGreenCAFeatures of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyBMJ2020369m198510.1136/bmj.m1985324444607243036
– reference: MenniCValdesAMFreidinMBReal-time tracking of self-reported symptoms to predict potential COVID-19Nat Med2020267103710401:CAS:528:DC%2BB3cXptVKhsrg%3D10.1038/s41591-020-0916-2323938047751267
– reference: Santos-LasaosaSPorta-EtessamJOnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infectionNeurologia20203552912941:STN:280:DC%2BB38vnt1Srsg%3D%3D10.1016/j.nrl.2020.05.004324107657221361
– reference: CherianSSAgrawalMBasuAPerspectives for repurposing drugs for the coronavirus disease 2019Indian J Med Res20201512 & 31601711:CAS:528:DC%2BB3cXhvVCgtbrO10.4103/ijmr.IJMR_585_20323174087357399
– reference: MartellettiPSchwedtTJLanteri-MinetMMy Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failedJ Headache Pain201819111510.1186/s10194-018-0946-z304821816755592
– reference: Angus-LeppanHGuiloffRJHeadache: basic trial designs, sample sizes and pitfallsClinical trials in neurology2001LondonSpringer27929010.1007/978-1-4471-3787-0_23
– reference: PattersonVNeurological telemedicine in the COVID-19 eraNat Rev Neurol202117273741:CAS:528:DC%2BB3cXisFentrnP10.1038/s41582-020-00438-933257883
– reference: SmithMNakamotoMCrockerJEarly impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: results of a quality improvement surveyHeadache202161114915610.1111/head.1403033316097
– reference: Oxford Centre for evidence based medicine (2011). www.cebm.net/ocebm-levels-of-evidence/. Accessed Nov 2020
– reference: UygunOErtasMEkizogluEHeadache characteristics in COVID-19 pandemic-a survey studyJ Headache Pain20202111211:CAS:528:DC%2BB3cXitFeqs77P10.1186/s10194-020-01188-1330508807552597
– reference: Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edn. In: Cephalalgia, vol 38, issue 1, pp 1–211. doi: https://doi.org/10.1177/0333102417738202
– reference: Planchuelo-GomezATrigoJde Luis-GarciaRDeep phenotyping of headache in hospitalized COVID-19 patients via principal component analysisFront Neurol20201158387010.3389/fneur.2020.583870333911527773780
– reference: SteinerTJScherAIStewartWFThe prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicityCephalalgia20032375195271:STN:280:DC%2BD3svns1GhsQ%3D%3D10.1046/j.1468-2982.2003.00568.x12950377
– reference: TommasiMToroFArnoSPhysical and psychological impact of the phase one lockdown for COVID-19 on ItaliansFront Psychol20201156372210.3389/fpsyg.2020.563722333910797773646
– reference: KurthTWinterACEliassenAHMigraine and risk of cardiovascular disease in women: prospective cohort studyBMJ2016353i261010.1136/bmj.i2610272472814887613
– reference: CanelLZisimopoulouSBessonMTopiramate-induced severe heatstroke in an adult patient: a case reportJ Med Case Rep2016109510.1186/s13256-016-0835-5270750334831160
– reference: LiptonRBBigalMEDiamondMMigraine prevalence, disease burden, and the need for preventive therapyNeurology20076853433491:STN:280:DC%2BD2s%2FlslCgsg%3D%3D10.1212/01.wnl.0000252808.97649.2117261680
– reference: NICE (2021) COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. https://www.nice.org.uk/advice/es23/chapter/Key-messages. Accessed Jan 2021
– reference: GelayeBSaccoSBrownWJBody composition status and the risk of migraine: a meta-analysisNeurology201788191795180410.1212/WNL.000000000000391954199815419981
– reference: ChenJSAlfajaroMMChowRDNon-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infectionJ Virol202110.1128/JVI.00014-21346138018428404
– reference: JangYEChoEYChoiHYDiagnostic neuroimaging in headache patients: a systematic review and meta-analysisPsychiatry Investig201916640741710.30773/pi.2019.04.11312476996603699
– reference: JamesHMPapoutsiCWhertonJSpread, scale-up, and sustainability of video consulting in health care: systematic review and synthesis guided by the NASSS frameworkJ Med Internet Res2021231e2377510.2196/23775334341417837451
– reference: Angus-LeppanHSaatciDSutcliffeAAbdominal migraineBMJ2018360k17910.1136/bmj.k17929459383
– reference: DublinSWalkerRLJacksonMLUse of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control studyJ Am Geriatr Soc201159101899190710.1111/j.1532-5415.2011.03586.x220915033223721
– reference: RavindranMKZhengYTimbolCMigraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studiesBMC Neurol2011113010.1186/1471-2377-11-30213757633058027
– reference: NaasaniICOMPARE analysis, a bioinformatic approach to accelerate drug repurposing against Covid-19 and other emerging epidemicsSLAS Discov20212633453511:CAS:528:DC%2BB3MXkvFCquro%3D10.1177/24725552209756723326771333267713
– reference: Porta-EtessamJGonzalez-GarciaNMatias-GuiuJAShould we adapt the prescription criteria for specific treatments for migraine due to the COVID-19 pandemic?Headache20206071448144910.1111/head.1388032526038
– reference: WakerleyBRMollanSPSinclairAJIdiopathic intracranial hypertension: update on diagnosis and managementClin Med (Lond)202020438438810.7861/clinmed.2020-0232
– reference: GuiloffRJFrunsMLimb pain in migraine and cluster headacheJNNP1988518102210311:STN:280:DyaL1M7htVejtA%3D%3D
– reference: MillerSSinclairAJDaviesBNeurostimulation in the treatment of primary headachesPract Neurol201616536237510.1136/practneurol-2015-001298271520275036247
– reference: TepperSJOpioids should not be used in migraineHeadache201252Suppl 1303410.1111/j.1526-4610.2012.02140.x22540203
– reference: KrishnamurthySLockeyRFKolliputiNSoluble ACE2 as a potential therapy for COVID-19Am J Physiol Cell Physiol1993303C279C2811:CAS:528:DC%2BB3MXhtVKjsLfP10.1152/ajpcell.00478.2020
– reference: DelussiMGentileECoppolaGInvestigating the effects of COVID-19 quarantine in migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe)Front Neurol20201159788110.3389/fneur.2020.597881332402137683429
– reference: ChatterjeeSCarnahanRMChenHAnticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control studyJ Am Geriatr Soc201664239440010.1111/jgs.1393226889844
– reference: DouglasMKatikireddiSVTaulbutMMitigating the wider health effects of covid-19 pandemic responseBMJ2020369m155710.1136/bmj.m1557323410027184317
– reference: SafadiKKrugerJMChowersIOphthalmology practice during the COVID-19 pandemicBMJ Open Ophthalmol202051e00048710.1136/bmjophth-2020-00048732432169
– reference: RozenTDDaily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian/Asiatic fluCephalalgia202040131406140910.1177/0333102420965132331460347645599
– reference: WilliamsonEJWalkerAJBhaskaranKFactors associated with COVID-19-related death using OpenSAFELYNature202058478214304361:CAS:528:DC%2BB3cXhsFegtbzK10.1038/s41586-020-2521-476110747611074
– reference: VerhagenIEvan CasterenDSde VriesLSEffect of lockdown during COVID-19 on migraine: a longitudinal cohort studyCephalagia202110.1177/0333102420981739
– reference: GelfandAAPolandGMigraine treatment and COVID-19 vaccines: no cause for concernHeadache202110.1111/head.14086336169338013648
– reference: DoTPRemmersASchytzHWRed and orange flags for secondary headaches in clinical practice: SNNOOP10 listNeurology201992313414410.1212/WNL.0000000000006697305875186340385
– reference: TanHSFrereZKrishnamoorthyVAssociation of gabapentinoid utilization with postoperative pulmonary complications in gynecologic surgery: a retrospective cohort studyCurr Med Res Opin202110.1080/03007995.2021.190009234543161
– reference: BolayHOzgeAUluduzDAre migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities?Headache202060102508252110.1111/head.1399833124044
– reference: LiuAMenonSColsonNJAnalysis of the MTHFR C677T variant with migraine phenotypesBMC Res Notes201032131:CAS:528:DC%2BC3cXpslaqsrw%3D10.1186/1756-0500-3-213206632282919563
– reference: Lopez-LeonSWegman-OstroskyTPerelmanCMore than 50 long-term effects of COVID-19: a systematic review and meta-analysisRes Sq202110.21203/rs.3.rs-266574/v1336886427941645
– reference: KandasamyMPerspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19Med Drug Discov2020610004210.1016/j.medidd.2020.100042323520817189194
– reference: CaronnaEBallveALlauradoAHeadache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolutionCephalalgia202040131410142110.1177/0333102420965157331460367645597
– reference: NHS England (2020) Improved NHS migraine care to save thousands of hospital stays. https://www.england.nhs.uk/2020/01/improved-nhs-migraine-care/. Accessed Dec 2020
– reference: UnalGTuranBBalciogluYHImmunopharmacological management of COVID-19: potential therapeutic role of valproic acidMed Hypotheses20201431098911:CAS:528:DC%2BB3cXhtVGls77I10.1016/j.mehy.2020.1098913249800732498007
– volume: 18
  start-page: 106
  issue: 1
  year: 2017
  ident: 10610_CR52
  publication-title: J Headache Pain
  doi: 10.1186/s10194-017-0816-0
– volume: 151
  start-page: 160
  issue: 2 & 3
  year: 2020
  ident: 10610_CR57
  publication-title: Indian J Med Res
  doi: 10.4103/ijmr.IJMR_585_20
– year: 2020
  ident: 10610_CR53
  publication-title: Neurol Sci
  doi: 10.1007/s10072-020-04702-0
– ident: 10610_CR1
– ident: 10610_CR62
– volume: 3
  start-page: 213
  year: 2010
  ident: 10610_CR25
  publication-title: BMC Res Notes
  doi: 10.1186/1756-0500-3-213
– year: 2021
  ident: 10610_CR46
  publication-title: Curr Med Res Opin
  doi: 10.1080/03007995.2021.1900092
– volume: 64
  start-page: 394
  issue: 2
  year: 2016
  ident: 10610_CR47
  publication-title: J Am Geriatr Soc
  doi: 10.1111/jgs.13932
– volume: 16
  start-page: 362
  issue: 5
  year: 2016
  ident: 10610_CR50
  publication-title: Pract Neurol
  doi: 10.1136/practneurol-2015-001298
– volume: 40
  start-page: 1410
  issue: 13
  year: 2020
  ident: 10610_CR67
  publication-title: Cephalalgia
  doi: 10.1177/0333102420965157
– volume: 360
  start-page: k179
  year: 2018
  ident: 10610_CR15
  publication-title: BMJ
  doi: 10.1136/bmj.k179
– ident: 10610_CR5
– volume: 11
  start-page: 563722
  year: 2020
  ident: 10610_CR28
  publication-title: Front Psychol
  doi: 10.3389/fpsyg.2020.563722
– volume: 26
  start-page: 1037
  issue: 7
  year: 2020
  ident: 10610_CR17
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0916-2
– volume: 11
  start-page: 30
  year: 2011
  ident: 10610_CR70
  publication-title: BMC Neurol
  doi: 10.1186/1471-2377-11-30
– volume: 11
  start-page: 583870
  year: 2020
  ident: 10610_CR20
  publication-title: Front Neurol
  doi: 10.3389/fneur.2020.583870
– year: 2021
  ident: 10610_CR29
  publication-title: Cephalagia
  doi: 10.1177/0333102420981739
– volume: 61
  start-page: 351
  issue: 2
  year: 2021
  ident: 10610_CR64
  publication-title: Headache
  doi: 10.1111/head.14056
– volume: 20
  start-page: 384
  issue: 4
  year: 2020
  ident: 10610_CR36
  publication-title: Clin Med (Lond)
  doi: 10.7861/clinmed.2020-0232
– volume: 52
  start-page: 30
  issue: Suppl 1
  year: 2012
  ident: 10610_CR43
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2012.02140.x
– year: 2021
  ident: 10610_CR42
  publication-title: J Virol
  doi: 10.1128/JVI.00014-21
– volume: 23
  start-page: e23775
  issue: 1
  year: 2021
  ident: 10610_CR32
  publication-title: J Med Internet Res
  doi: 10.2196/23775
– ident: 10610_CR34
  doi: 10.1177/0333102417738202
– year: 2021
  ident: 10610_CR63
  publication-title: Headache
  doi: 10.1111/head.14086
– volume: 51
  start-page: 1022
  issue: 8
  year: 1988
  ident: 10610_CR24
  publication-title: JNNP
– volume: 11
  start-page: 565
  year: 2020
  ident: 10610_CR18
  publication-title: Front Neurol
  doi: 10.3389/fneur.2020.00565
– volume: 59
  start-page: 1899
  issue: 10
  year: 2011
  ident: 10610_CR44
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2011.03586.x
– volume: 126
  start-page: 1682
  issue: 12
  year: 2020
  ident: 10610_CR60
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.120.317174
– volume: 21
  start-page: 115
  issue: 1
  year: 2020
  ident: 10610_CR22
  publication-title: J Headache Pain
  doi: 10.1186/s10194-020-01183-6
– volume: 60
  start-page: 2176
  issue: 10
  year: 2020
  ident: 10610_CR23
  publication-title: Headache
  doi: 10.1111/head.13967
– volume: 23
  start-page: 519
  issue: 7
  year: 2003
  ident: 10610_CR10
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2003.00568.x
– volume: 40
  start-page: 1406
  issue: 13
  year: 2020
  ident: 10610_CR69
  publication-title: Cephalalgia
  doi: 10.1177/0333102420965132
– volume: 13
  start-page: 308
  issue: 5
  year: 2013
  ident: 10610_CR14
  publication-title: Pract Neurol
  doi: 10.1136/practneurol-2012-000502
– volume: 174
  start-page: W25
  issue: 2
  year: 2021
  ident: 10610_CR48
  publication-title: Ann Intern Med
  doi: 10.7326/L20-1446
– volume: 23
  start-page: 476
  issue: 3
  year: 2021
  ident: 10610_CR49
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.2060
– volume: 6
  start-page: 100042
  year: 2020
  ident: 10610_CR61
  publication-title: Med Drug Discov
  doi: 10.1016/j.medidd.2020.100042
– volume: 35
  start-page: 291
  issue: 5
  year: 2020
  ident: 10610_CR65
  publication-title: Neurologia
  doi: 10.1016/j.nrl.2020.05.004
– volume: 21
  start-page: 121
  issue: 1
  year: 2020
  ident: 10610_CR21
  publication-title: J Headache Pain
  doi: 10.1186/s10194-020-01188-1
– volume: 16
  start-page: 407
  issue: 6
  year: 2019
  ident: 10610_CR38
  publication-title: Psychiatry Investig
  doi: 10.30773/pi.2019.04.11
– volume: 60
  start-page: 2508
  issue: 10
  year: 2020
  ident: 10610_CR7
  publication-title: Headache
  doi: 10.1111/head.13998
– volume: 5
  start-page: e000487
  issue: 1
  year: 2020
  ident: 10610_CR37
  publication-title: BMJ Open Ophthalmol
  doi: 10.1136/bmjophth-2020-000487
– ident: 10610_CR39
– ident: 10610_CR3
– volume: 11
  start-page: 597881
  year: 2020
  ident: 10610_CR30
  publication-title: Front Neurol
  doi: 10.3389/fneur.2020.597881
– volume: 92
  start-page: 134
  issue: 3
  year: 2019
  ident: 10610_CR35
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000006697
– year: 2021
  ident: 10610_CR68
  publication-title: Res Sq
  doi: 10.21203/rs.3.rs-266574/v1
– volume: 23
  start-page: S311
  issue: 4S
  year: 2020
  ident: 10610_CR51
  publication-title: Pain Physician
– volume: 898
  start-page: 173988
  year: 2021
  ident: 10610_CR56
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2021.173988
– volume: 17
  start-page: 73
  issue: 2
  year: 2021
  ident: 10610_CR31
  publication-title: Nat Rev Neurol
  doi: 10.1038/s41582-020-00438-9
– start-page: 279
  volume-title: Clinical trials in neurology
  year: 2001
  ident: 10610_CR19
  doi: 10.1007/978-1-4471-3787-0_23
– volume: 61
  start-page: 149
  issue: 1
  year: 2021
  ident: 10610_CR26
  publication-title: Headache
  doi: 10.1111/head.14030
– volume: 19
  start-page: 115
  issue: 1
  year: 2018
  ident: 10610_CR4
  publication-title: J Headache Pain
  doi: 10.1186/s10194-018-0946-z
– volume: 88
  start-page: 1795
  issue: 19
  year: 2017
  ident: 10610_CR11
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000003919
– volume: 26
  start-page: 345
  issue: 3
  year: 2021
  ident: 10610_CR54
  publication-title: SLAS Discov
  doi: 10.1177/2472555220975672
– volume: 584
  start-page: 430
  issue: 7821
  year: 2020
  ident: 10610_CR9
  publication-title: Nature
  doi: 10.1038/s41586-020-2521-4
– volume: 77
  start-page: 683
  issue: 6
  year: 2020
  ident: 10610_CR16
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2020.1127
– volume: 68
  start-page: 343
  issue: 5
  year: 2007
  ident: 10610_CR13
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000252808.97649.21
– volume: 60
  start-page: 1448
  issue: 7
  year: 2020
  ident: 10610_CR66
  publication-title: Headache
  doi: 10.1111/head.13880
– volume: 369
  start-page: m1985
  year: 2020
  ident: 10610_CR8
  publication-title: BMJ
  doi: 10.1136/bmj.m1985
– volume: 104
  start-page: 452
  issue: 3
  year: 2021
  ident: 10610_CR33
  publication-title: Patient Educ Couns
  doi: 10.1016/j.pec.2020.12.027
– volume: 11
  start-page: 875
  issue: 8
  year: 2005
  ident: 10610_CR59
  publication-title: Nat Med
  doi: 10.1038/nm1267
– volume: 353
  start-page: i2610
  year: 2016
  ident: 10610_CR12
  publication-title: BMJ
  doi: 10.1136/bmj.i2610
– volume: 369
  start-page: m1557
  year: 2020
  ident: 10610_CR27
  publication-title: BMJ
  doi: 10.1136/bmj.m1557
– ident: 10610_CR40
– ident: 10610_CR6
– volume: 30
  start-page: C279
  issue: 3
  year: 1993
  ident: 10610_CR58
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00478.2020
– volume: 143
  start-page: 109891
  year: 2020
  ident: 10610_CR55
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2020.109891
– volume: 17
  start-page: 954
  issue: 11
  year: 2018
  ident: 10610_CR2
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(18)30322-3
– volume: 10
  start-page: 95
  year: 2016
  ident: 10610_CR45
  publication-title: J Med Case Rep
  doi: 10.1186/s13256-016-0835-5
– volume: 21
  start-page: 38
  issue: 1
  year: 2020
  ident: 10610_CR41
  publication-title: J Headache Pain
  doi: 10.1186/s10194-020-01106-5
SSID ssib000606046
ssib058493272
ssib006157831
ssib017358186
ssib021655071
ssib016498012
ssib004208253
ssib002805310
ssib059160281
ssj0008459
Score 2.4014158
Snippet The worldwide treatment gap for migraine before COVID-19 inevitably widens as attention focuses on an international emergency. Migraine hits people...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
nii
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4388
SubjectTerms Acupuncture
Botulinum toxin
Communicable Disease Control
Coronary artery disease
Coronaviruses
COVID-19
COVID-19 - complications
Diabetes mellitus
Headache
Heart diseases
Humans
Immunosuppression
Long COVID
Medicine
Medicine & Public Health
Migraine
Migraine Disorders
Migraine Disorders - epidemiology
Migraine Disorders - therapy
Neurological Update
Neurology
Neuroradiology
Neurosciences
Pandemics
Post-Acute COVID-19 Syndrome
Quality of Life
Respiratory diseases
Risk factors
Telemedicine
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RIiEuiDcpLTISN7C0TvwKt1WhKkiUC4t6i_xKiUTTFd1t_z4z3iRooSBxSQ6eWM7M2J7xjL8BeFUZH0lVuJcicYmbCLcx1jw5L7zW3rYxo32e6OOF_HiqTodLYZdjtvsYkswr9XTZjaCh6DYxpWDhps-vd-C2It8dtXhRzqf118pcIm1WyRlXlZLDVZmb-9jajnb6rrvJ0vwzYfK3qGnejI7uw73BimTzjdgfwK3UP4Q7n4Y4-SOYn7irjJ3Rn7Hz7ozKQCRGSV5sqMuD78QOP3_98I6Lmi3pJPm8C2-Z69l6SYcAj2Fx9P7L4TEfiiXwoHS94lIE6Z1RMngpSy99HdA38S2lsFrXxkB10lUU0SRlHJIiI2ZJlTGhi1q2rnoCu_1Fn54Bs6Fqg_E61DHJtpK-NaZulfDJWiedKkCMPGvCgCROBS2-NxMGcuZzg3xuMp-b6wJeT98sNzga_6Q-QFFg5_QU6NNJCgAbnYOqWssC9kchNcOcu2xKZTd4fLqAl1MzzhYKgbg-XayJprR06GmqAp5uZDoNB_WFwIBEAWZL2hMBIXFvt_Tdt4zIjVaSRcOrgDejXvwa1t__cu__yJ_D3TJrLp3_7MPu6sc6HaBFtPIv8gT4CafV_gc
  priority: 102
  providerName: Springer Nature
Title Navigating migraine care through the COVID-19 pandemic: an update
URI https://cir.nii.ac.jp/crid/1871428067638913664
https://link.springer.com/article/10.1007/s00415-021-10610-w
https://www.ncbi.nlm.nih.gov/pubmed/34002281
https://www.proquest.com/docview/2580828596
https://www.proquest.com/docview/2528814673
https://pubmed.ncbi.nlm.nih.gov/PMC8128091
Volume 268
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUK8IMbXAtsUJN7Aok7s2NkLareWAaIgRFF5ivyVEYmlhbXbv4_PdTOVj73ED75E8fls35d_B_A8F9qiqBDNqCPMHyJEWlsSpzTVRaFlbQPa57g4nbB3Uz6NDreLmFa53hPDRm1nBn3krzIuV2hrxev5T4JVozC6GktobMEOQpdhSpeYdgZXT7JQLK2Xsx7hOWfx0ky4OodAU3g3GRO6vApBrjYOpq22af6lc_6dOvlH_DQcS6N7cDfqk2l_JQC7cMu19-H2hxgxfwD9sboMKBrtWXrenGFBCJdiulcaK_T41qXHH7--PSG0TOfoUz5vzFGq2nQ5R3fAQ5iMhl-OT0ksm0AML8oFYdQwrQRnRjOWaaZL460UXWMyq1S1NVgxnVtqheNCeVLPiJ7jmXXeWM1qlT-C7XbWuj1IpclrI3RhSutYnTNdC1HWnGonpWKKJ0DXPKtMxBTH0hY_qg4NOfC58nyuAp-rqwRedO_MV4gaN1If-KnwH8cn9dYdw1CwKEJ4tShYAvvrSari6ruormUlgWddt183GAxRrZstkSaT6P4UeQKPV3Pa_Y6XF4QFogmIjdnuCBCTe7Onbb4HbG6vL0mvgiXwci0X17_1_1E-uXkUT-FOFiQVPT_7sL34tXQHXhda6MMg8Iew0x8NBmNs33x7P_TtYDj-9Nn3TrL-bxocBno
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB61Wwl4QdwEWjASPIHFJrFjBwmh0kO7tF0QalHfgq-UlWh2obus-FP8RjzOUS1H3_qSPMSx7JmxPZe_AXiaCm1RVKhmsaPMHyJUWptTp3Sss0zL0ga0z1E2OGLvjvnxCvxq78JgWmW7J4aN2k4M-shfJlzWaGvZm-k3ilWjMLraltCoxWLP_Vx4k-3s9XDb8_dZkuzuHG4NaFNVgBqe5TPKYsO0EpwZzViimc6NV-J1ibmeUpXWYEFxbmMrHBfKN_VHXN_xxDpvyyWlSn2_q7DGUm_K9GDt7c7ow8du75cslGfrp6xPecpZc00nXNZDaCu8DY0pZF5poYulo3C1Go__peX-naz5R8Q2HIS7N-B6o8GSzVrkbsKKq27BlYMmRn8bNkfqR8DtqE7I6fgES1A4gglmpKkJ5N-ObL3_NNymcU6m6MU-HZtXRFVkPkUHxB04uhSS3oVeNancfSDSpKUROjO5daxMmS6FyEseayelYopHELc0K0yDYo7FNL4WHf5yoHPh6VwEOheLCJ53_0xrDI8LW294VvjO8Rl7e5Jh8FlkIaCbZSyC9ZZJRbPez4pz6YzgSffZr1QMv6jKTebYJpHocBVpBPdqnnbD8fKCQERxBGKJ210DRAFf_lKNvwQ0cK-hSa_0RfCilYvzYf1_lg8unsVjuDo4PNgv9oejvYdwLQlSi36ndejNvs_dhtfEZvpRI_4EPl_2ivsNwVY_QA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61Raq4IN4EWjASnMDqOrHjBAmhqsuqS2HhQNHegl8pkWh2obus-Gv8OjzOo1oevfWSHOJY9jzs8cz4G4AnidQWRYVqzhzlfhOhmbU5dUoznaY6K21A-5ykh8f8zVRMN-BXdxcG0yq7NTEs1HZm0Ee-F4usQVtL98o2LeLDcPRq_o1iBSmMtHblNBoROXI_V_74dvZyPPS8fhrHo9cfDw5pW2GAGpHmC8qZ4VpJwY3mPNZc58Yb9LrEvM9MldZgcXFhmZVOSOWb-u1u4ERsnT_XxaVKfL-bcEUmgqGOyWl_2BtkPBRqGyR8QEUieHthJ1zbQ5ArvBeNyWTefKGrtU1xs66qf9m7f6dt_hG7DVvi6Dpca21Zst8I3w3YcPVN2H7XRutvwf5E_QgIHvUJOa1OsBiFI5hqRtrqQP7tyMH7T-MhZTmZoz_7tDIviKrJco6uiNtwfCkEvQNb9ax294BkJimN1KnJreNlwnUpZV4Kpl2WKa5EBKyjWWFaPHMsq_G16JGYA50LT-ci0LlYRfCs_2feoHlc2HrXs8J3jk_mT5Ycw9AyDaHdNOUR7HRMKlrNPyvO5TSCx_1nr7MYiFG1my2xTZyh61UmEdxteNoPx8sLQhKxCOQat_sGiAe-_qWuvgRccG-rZd78i-B5Jxfnw_r_LO9fPItHsO31rHg7nhw9gKtxEFp0QO3A1uL70u16k2yhHwbZJ_D5spXtN2tOQhA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Navigating+migraine+care+through+the+COVID-19+pandemic%3A+an+update&rft.jtitle=Journal+of+neurology&rft.au=Angus-Leppan%2C+Heather&rft.au=Guiloff%2C+Angelica+E.&rft.au=Benson%2C+Karen&rft.au=Guiloff%2C+Roberto+J.&rft.date=2021-11-01&rft.issn=0340-5354&rft.eissn=1432-1459&rft.volume=268&rft.issue=11&rft.spage=4388&rft.epage=4395&rft_id=info:doi/10.1007%2Fs00415-021-10610-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00415_021_10610_w
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon